Siam Capital

Siam Capital is a venture capital firm based in New York, founded in 2021. The firm is dedicated to investing in companies at the intersection of sustainability, consumer needs, and technology. Its focus is on identifying and supporting innovative ventures that aim to improve both people's lives and the health of the planet. By targeting sectors that promote sustainable practices and technological advancements, Siam Capital seeks to facilitate positive change and drive progress in the marketplace.

Sita Chantramonklasri

Founder and General Partner

Past deals in Infants

Helaina

Series B in 2024
Helaina is a biotechnology company focused on producing milk-equivalent baby formula that serves as an alternative to breast milk. By utilizing fermentation, Helaina generates bioactive proteins that closely mimic the functional proteins found in human milk, creating a new category of functional food products. These products are designed to provide nutritional options and immune benefits similar to those of breast milk, offering infants a viable alternative that incorporates the immune-nourishing properties of natural breast milk. Helaina's innovative approach aims to enhance infant nutrition and support healthy development.

Evereden

Series C in 2021
Evereden is a skincare brand focused on providing nourishing self-care products designed for the entire family, with a particular emphasis on baby-safe cosmetics. The company formulates its offerings using high-quality, natural ingredients such as cold-processed organic sunflower seed oil, avocado oil, and grapeseed oil. Evereden's product line includes baby creams, healing balms, firming lotions, and belly masks, all crafted to be anti-allergic and safe for infants. This commitment to quality allows parents to choose from a variety of effective skincare solutions for both themselves and their children, promoting overall skin health within the family.

Helaina

Series A in 2021
Helaina is a biotechnology company focused on producing milk-equivalent baby formula that serves as an alternative to breast milk. By utilizing fermentation, Helaina generates bioactive proteins that closely mimic the functional proteins found in human milk, creating a new category of functional food products. These products are designed to provide nutritional options and immune benefits similar to those of breast milk, offering infants a viable alternative that incorporates the immune-nourishing properties of natural breast milk. Helaina's innovative approach aims to enhance infant nutrition and support healthy development.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.